- Home
- SLN vs VCIC Comparison
SLN vs VCIC Comparison
Compare SLN & VCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLN
- VCIC
- Stock Information
- Founded
- SLN 1994
- VCIC 2024
- Country
- SLN United Kingdom
- VCIC United States
- Employees
- SLN N/A
- VCIC N/A
- Industry
- SLN Biotechnology: Pharmaceutical Preparations
- VCIC
- Sector
- SLN Health Care
- VCIC
- Exchange
- SLN Nasdaq
- VCIC NYSE
- Market Cap
- SLN 352.2M
- VCIC 295.4M
- IPO Year
- SLN N/A
- VCIC 2024
- Fundamental
- Price
- SLN $4.79
- VCIC $10.10
- Analyst Decision
- SLN Buy
- VCIC
- Analyst Count
- SLN 4
- VCIC 0
- Target Price
- SLN $46.25
- VCIC N/A
- AVG Volume (30 Days)
- SLN 339.1K
- VCIC 9.8K
- Earning Date
- SLN 02-27-2025
- VCIC 01-01-0001
- Dividend Yield
- SLN N/A
- VCIC N/A
- EPS Growth
- SLN N/A
- VCIC N/A
- EPS
- SLN N/A
- VCIC N/A
- Revenue
- SLN $21,773,221.00
- VCIC N/A
- Revenue This Year
- SLN N/A
- VCIC N/A
- Revenue Next Year
- SLN $104.98
- VCIC N/A
- P/E Ratio
- SLN N/A
- VCIC N/A
- Revenue Growth
- SLN N/A
- VCIC N/A
- 52 Week Low
- SLN $4.06
- VCIC $9.96
- 52 Week High
- SLN $27.72
- VCIC $10.99
- Technical
- Relative Strength Index (RSI)
- SLN 41.33
- VCIC N/A
- Support Level
- SLN $4.71
- VCIC N/A
- Resistance Level
- SLN $5.16
- VCIC N/A
- Average True Range (ATR)
- SLN 0.47
- VCIC 0.00
- MACD
- SLN 0.08
- VCIC 0.00
- Stochastic Oscillator
- SLN 32.74
- VCIC 0.00
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.
About VCIC VINE HILL CAP INVT CORP
Vine Hill Capital Investment Corp is a blank check company.